SynBioVen is a venture capital firm focused on early-stage synthetic biology companies in the United Kingdom. It backs PoC, pre-seed, seed and Series A-stage companies across biotechnology, life sciences, agtech, deep tech and materials, with an emphasis on expert access and R&D support for founders building biology-enabled technologies.